> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Joint Advisory Panel Discussing Achondroplasia Amended
- URL: https://www.fdaweb.com/joint-advisory-panel-discussing-achondroplasia-amended/
- Published: 2018-03-16T12:00:00.000Z
- Updated: 2026-09-14T23:53:41.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5141003

*Federal Register* notice: FDA has amended a 1/23 notice about a 3/22 Pediatric Advisory Committee and Endocrinologic and Metabolic Drugs Advisory Committee meeting to reflect a change in the agenda for the open session of the meeting and to extend the amount of time allotted for the closed session. The panels are scheduled to discuss drug development for the treating children with achondroplasia. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-03-16/pdf/2018-05413.pdf?ref=fdaweb.com).